Advanced Therapy Medicinal Products in Vitiligo: Current Status, Future Prospects, and Approved Treatments
March 2023
in “
PubMed
”
vitiligo topical corticosteroids calcineurin inhibitors phototherapies advanced therapy medicinal products non-cultured epidermal cells melanocytes hair follicle melanocytes mesenchymal stem cells multi-lineage differentiating stress enduring cells autologous suspension of keratinocytes and melanocytes
Studysummary This review discusses the potential of advanced therapy medicinal products for treating vitiligo, highlighting promising results but noting affordability remains a challenge; no new clinical results were reported.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on pmc.ncbi.nlm.nih.gov →